(Q33824823)

29 July 2017

1 reference

title

Guidelines for monitoring patients taking tamoxifen treatment (English)

1 reference

29 July 2017

1 reference

P Neven

1

1 reference

PubMed ID

10647972

29 July 2017

H Vernaeve

series ordinal

2

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

22

1 reference

29 July 2017

1

1 reference

29 July 2017

1-11

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200022010-00001

29 July 2017

0 references

cites work

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200022010-00001

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200022010-00001

The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.

21 January 2018

1 reference

12 December 2020

The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen

1 reference

12 December 2020

Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer

1 reference

12 December 2020

Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy

1 reference

12 December 2020

The effects of tamoxifen on the endometrium, blood flow of the uterine arteries and serum lipoprotein (a) levels in postmenopausal women.

1 reference

12 December 2020

Sonohysterography for endometrial abnormalities: preliminary results

1 reference

12 December 2020

Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.

1 reference

12 December 2020

Variation in endometrial thickening in women with amenorrhea on tamoxifen

1 reference

12 December 2020

Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen

1 reference

12 December 2020

Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial

1 reference

12 December 2020

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

1 reference

12 December 2020

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment

1 reference

12 December 2020

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Endometrial cancer in polyps associated with tamoxifen use

1 reference

12 December 2020

The Molecular Pharmacology of SERMs

1 reference

12 December 2020

Endometrial lesions in patients undergoing tamoxifen therapy

1 reference

12 December 2020

ACOG committee opinion. Tamoxifen and endometrial cancer. Number 169, February 1996. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists

1 reference

12 December 2020

Synthetic oestrogens in mammary cancer

1 reference

12 December 2020

Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening

1 reference

12 December 2020

A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen.

1 reference

12 December 2020

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

12 December 2020

Should tamoxifen users be screened for endometrial lesions?

1 reference

12 December 2020

Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment

1 reference

12 December 2020

Hysteroscopic follow-up during tamoxifen treatment

1 reference

12 December 2020

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

12 December 2020

Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features

1 reference

12 December 2020

Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding

1 reference

12 December 2020

A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization

1 reference

12 December 2020

Uterine side effects of tamoxifen: a need for systematic pretreatment screening

1 reference

12 December 2020

Tamoxifen and the uterus and endometrium

1 reference

12 December 2020

The effects of tamoxifen on the endometrium

1 reference

12 December 2020

Adjuvant tamoxifen in early-stage breast cancer: effects on intercurrent morbidity and mortality

1 reference

12 December 2020

Controversies regarding tamoxifen and uterine carcinoma

1 reference

12 December 2020

OVARIAN SECRETION AND TUMOR INCIDENCE

1 reference

12 December 2020

Comparison of real-time ultrasonography, hysterosalpingography, and laparoscopy/hysteroscopy in the evaluation of uterine abnormalities and tubal patency

1 reference

12 December 2020

Tamoxifen and the uterus

1 reference

12 December 2020

Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted Triphenylethylenes

1 reference

12 December 2020

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

12 December 2020

Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen

1 reference

12 December 2020

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

12 December 2020

Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients

1 reference

12 December 2020

Tamoxifen therapy for breast cancer and endometrial cancer risk.

1 reference

12 December 2020

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

12 December 2020

Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial

1 reference

12 December 2020

Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer

1 reference

12 December 2020

Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.

1 reference

12 December 2020

Endometrial thickness and ovarian cysts as measured by ultrasound in asymptomatic postmenopausal breast cancer patients on various adjuvant treatments including tamoxifen

1 reference

12 December 2020

Longitudinal hysteroscopic follow-up during tamoxifen treatment

1 reference

12 December 2020

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

1 reference

12 December 2020

10.2165/00002018-200022010-00001

Identifiers

DOI

1 reference

PubMed ID

10647972

Dimensions Publication ID

29 July 2017

0 references

1 reference

PubMed ID

10647972